Recently, the "Recombinant Collagen Liquid Dressing," independently developed by Jiangsu Yaohai Novagen Biotechnology Co., Ltd., has officially received the Medical Device Registration Certificate (Registration Certificate No.: Su Xie Zhun 20252142115) issued by the Jiangsu Medical Products Administration. This achievement not only demonstrates the company's profound technical expertise in the fields of biomaterials and skincare but also marks a solid step forward on its path toward compliant and professional development in the medical device sector.

Indications for Use

It is suitable for the care of non-chronic wounds (such as superficial wounds, and wounds following laser/photonic/chemical peel/micro-aesthetic procedures) and the surrounding skin. The product is provided in a sterile state, sterilized by moist heat, and intended for single use.

Recombinant Collagen

As the core functional ingredient of the newly approved product, the recombinant humanized Type III collagen is independently developed and commercially produced by Yaohai's R&D team. With an amino acid sequence identical to the human body's own Type III collagen, this raw material boasts 100% humanization, excellent biocompatibility, high purity, low endotoxin levels, and hypoallergenic properties. It is protected by independent core patents. "We firmly believe that only by mastering core raw material technology can we achieve ultimate control over product safety, efficacy, and quality." Yaohai Novagen has been focused on the R&D of recombinant collagen since its establishment. The approval of this registration certificate stands as strong proof of the company's long-term commitment to technological investment and independent innovation.

Jiangsu Yaohai Novagen Biotechnology Co., Ltd. consistently upholds the philosophy of "Biosynthesis, Naturally Beautiful," dedicated to the research, development, and translation of synthetic biomaterials. The successful registration of the "Recombinant Collagen Liquid Dressing" is a significant milestone in Yaohai Novagen's journey of independent innovation in medical devices and represents full recognition of the company's R&D capabilities and quality management system.

Moving forward, we will continue to increase R&D investment, deepen our product portfolio, and provide the industry and consumers with more safe, effective, and reliable solutions for skincare and wound repair.